- Home
- KROS vs LPTH Comparison
KROS vs LPTH Comparison
Compare KROS & LPTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | LPTH |
|---|---|---|
| Founded | 2015 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 563.1M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | KROS | LPTH |
|---|---|---|
| Price | $11.71 | $12.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $21.86 | $13.33 |
| AVG Volume (30 Days) | 253.7K | ★ 3.2M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $243,864,000.00 | $37,202,630.00 |
| Revenue This Year | N/A | $83.04 |
| Revenue Next Year | $2,751.79 | $24.83 |
| P/E Ratio | $5.20 | ★ N/A |
| Revenue Growth | N/A | ★ 17.26 |
| 52 Week Low | $10.42 | $2.28 |
| 52 Week High | $22.55 | $16.53 |
Technical Indicators
Market Signals| Indicator | KROS | LPTH |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 47.67 |
| Support Level | $10.64 | $9.84 |
| Resistance Level | $12.65 | $13.28 |
| Average True Range (ATR) | 0.47 | 1.52 |
| MACD | 0.10 | -0.24 |
| Stochastic Oscillator | 62.41 | 25.85 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.